Roche's CEO said on Wednesday that the Swiss drugmaker's oral drug candidate for breast cancer giredestrant could enter a ...

Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...

In Boston, we remember his Red Sox career from 1971-78. Specifically, the 1975 season when Tiant had 18 wins and 18 complete ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

The agreement's goal is to bring a blood-based test to market to stratify patients with traumatic brain injuries.

Basecamp Research, a biotechnology company that uses artificial intelligence to discover novel proteins and to help create ...

The skin problems experienced by women during the menopausal years may seem similar to a teenager’s, but they need to be ...

Bank Alfalah, a leading commercial bank in Pakistan, has partnered with Cancer Foundation Hospital, a leading non-profit ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

From forwards who became world stars to loyal club men who were brought in for next to nothing, our writers make their choices ...

This aesthetic begins at the facade, where vertical wall cladding, glazing bars on the windows and cross detailing nod to ...